Latest from Healthcare
TrialReach adds Octopus Investments to list of investors through £2 million venture capital deal
Octopus Investments has led a £2 million investment into clinical trials platform TrialReach alongside Amadeus Capital Partners.
Oxford-based medical technology firm secures investment from The North West Fund for Biomedical
Cerus Endovascular is moving its operations to Liverpool Science Park following backing from The North West Fund for Biomedical.
Investment for business growth: Springfield Healthcare Group
Care home operator Springfield Healthcare Group has already begun to use its Business Growth Fund cash to get acquisitive. We find out how progress has been since the investment as part of an exclusive portfolio roundtable.
Dementia diagnosis firm Cambridge Cognition picks AIM to fund its growth
Neuropsychological testing business Cambridge Cognition has joined London's Alternative Investment Market.
Springfield Homecare Services makes first Business Growth Fund-backed acquisition
Business Growth Fund portfolio company Springfield Homecare Services has closed its first acquisition since the business was supported by the bank-backed fund in June 2012.
Kurt Geiger backer Graphite Capital sells Optimum Care to Terra Firma business
The private equity firm behind investments in Wagamama and Paperchase has sold its stake in Optimum Care through a trade sale.
MabLyte and Watertronix backed by new Mercia Fund Management hybrid EIS and SEIS fund
Two new investments for Mercia Fund Management has kicked off its Mercia Growth Fund 1 efforts.
ISIS Equity Partners makes first investment of 2013 and backs Create Health
A £5 million investment from Isis Equity Partners' Baronsmead VCTs will be used to aid the development of a new fertility clinic for Create Health.
YFM Equity Partners exits Fishawack in deal with Growth Capital Partners
Medical communications agency Fishawack has a new private equity backer through a secondary buy-out deal.
Seven-figure seed round for Taragenyx four months after launch
Scottish medical technologies company Taragenyx has secured itself £1.3 million of seed capital to speed up the development of its orthopaedic and dental implant coatings.
Invesco Asset Management makes healthcare play with medicine investment
A £25 million fundraising for infirst HEALTHCARE will be used to launch the company's medicines into the US market.
Albion Ventures secures the NHS as trade buyer for Nelson House development
A first joint venture hospital acquisition between the NHS and a private healthcare provider has resulted in the purchase of a mental health rehabilitation institution.
Seven-figure funding injection for medical business Diagnostic Healthcare
A £1 million investment from The North West Fund for Biomedical is set to be used by Diagnostic Healthcare to expand its portfolio of medical equipment.
Expansion purchase for Care UK as it snaps up UK Specialist Hospitals
Care UK has closed the acquisition of UK Specialist Hospitals to expand its resources and expertise.
Wellington Partners portfolio company secures top-up funding from INKEF Capital
Medical technology company Sapiens Steering Brain Stimulation has secured a further €7.5 million (£6.6 million) investment to add to the Series A funding it began in 2011.
Envestors sews up angel backing for surgery tool business Cipher Surgical
Angel network Envestors has tapped into an investor pool in Monaco to secure backing for Cipher Surgical.
Biotechnology firm with prime ministerial approval nets capital market growth funds
AIM-listed drug discovery and development company e-Therapeutics is to raise £40 million via an issue of shares to new and existing institutional backers.
Albion Ventures adds to healthcare portfolio by backing MyMeds&Me
Investment firm Albion Ventures has added MyMeds&Me to its portfolio through a £2 million transaction.
The North West Fund for Biomedical moves past £10 million mark with LumbaCurve backing
A £125,000 equity investment allocation has been secured by LumbaCurve International to aid in its efforts to conduct market development and a clinical effectiveness study for its lower back pain treatment.
Irish biotech firm Algae Health nets funding to target exporting
An investment of €1 million (£854,000) is set to allow biotech business Algae Health to recruit an extra 23 people in the coming three years.
More from GrowthBusiness
The Entrepreneur
Diversifying the client base at launch and learning to say ‘No’
David Barker reflects on resisting the temptation to say 'Yes' to the first offer when he opened his data centre, and how choosing instead to diversify his client base at launch has enabled 4D Data Centres to maintain rapid growth in a recession.
Growing A Business
Light touch regulation: Friend or foe?
Sophia Harrison, director of financial and professional services at Grayling, looks at how a new exchange platform out of Sweden could strike the right chord of regulation for SMEs.
Comment & Analysis
Channeling Instagram for start-up success
That a team of 13 could build a business worth $1 billion should be the inspiration that all entrepreneurs need.
Research
The rise of cash shells
New research from GrowthBusiness shows that the number of UK cash shells is climbing. We speak to new entrants to the market and those that have recently closed deals to find out what’s driving shells’ increasing popularity.
